Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

The New and Emerging Role of Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapeutics to Improve Long-Term Outcomes in Patients with Relapsing Multiple Sclerosis

Program Overview

This CME/CE activity is derived from content presented at the 6th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will review the science and mode of action for Bruton's Tyrosine Kinase (BTK) inhibitors. The faculty will analyze the role of BTK in microglia and the clinical trial ...
View Course
Advanced Therapeutics in Movement Disorders

Program Overview

This CME program will highlight recent advances in the treatment and management of patients with Parkinson’s disease (PD), covering topics such as OFF episodes, deep brain stimulation (DBS) and psychosis. The expert faculty, led by Dr. Stuart Isaacson, will first delve into OFF episodes, analyzing the causes of OFF periods, and the impact on quality of life and ...
View Course
Addressing Healthcare Disparities and COVID-19 Concerns for All Patients with Multiple Sclerosis

Program Overview

This CME/CE symposium, led by Fred D. Lublin, MD, is derived from content presented at the Virtual ACTRIMS Forum in February, 2021. In this program, the expert faculty will review current disparities for the management of patients across the entire spectrum of disease with multiple sclerosis (MS). The faculty will discuss the immune-science relationship between COVID-19 infections and ...
View Course
Novel Targeted Therapies to Slow Disease Progression in Patients with Early-Stage Alzheimer’s Disease

Program Overview

This CE activity will highlight novel therapies to slow disease progression in patients with early-stage Alzheimer’s disease (AD), including data presented at the Virtual 13th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Digital Conference 2020. The expert faculty, led by Dr. Richard S. Isaacson, will first delve into the pathophysiology, early and accurate differential diagnosis and disease course ...
View Course
Anti-Programmed Cell Death (PD) Therapies for the Management of Patients with Lung Cancer

Program Overview

This CME program is derived from content presented at the 2020-2021 Eastern Pulmonary Conference Program. The expert faculty, Drs. Sidney S. Braman and M. Patricia Rivera, will first provide a review of current science in non-small cell lung cancer (NSCLC), including trends in stage distribution of lung cancer. Following, current data for targeted therapies as well as immunotherapies ...
View Course
Advances in Nontuberculous Mycobacterial Lung Disease: Improvement in Diagnosis, Treatment and Patient Quality of Life

Program Overview

This CME program is derived from content presented at the 2020-2021 Eastern Pulmonary Conference Program. The expert faculty, Drs. Sidney S. Braman and Charles L. Daley, will first highlight the prevalence and risk factors of nontuberculous mycobacterial lung disease (NTM-LD), as well as the importance of early diagnosis. Following, current criteria and treatment recommendations will be reviewed in ...
View Course

Upcoming Events

Alliance 46th Annual Conference

July 14th – 16th, 2021

CCR East Annual Meeting

August 12th-15th, 2021

CCR West Annual Meeting

September 18th – 21st, 2021

2021 Consortium of Multiple Sclerosis Centers Annual Meeting

October 25th – 28th, 2021